Technology | Intravascular Imaging | May 02, 2018

Conavi Medical’s Novasight Hybrid OCT/IVUS System Earns FDA Clearance

Hybrid system provides the resolution and contrast of OCT with the larger field of view of IVUS for imaging of coronary anatomy

May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Novasight Hybrid System. The system enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT). IVUS or OCT are typically used by interventional cardiologists to image coronary anatomy during angioplasty and stenting procedures.

The Novasight Hybrid System offers the capability to acquire both IVUS and OCT images using a single catheter. This provides the resolution and contrast of OCT with the larger field of view of IVUS, and displays the images in a precisely co-registered fashion, according to Brian Courtney, M.D., president and CEO of Conavi.

For more information: www.conavi.com

 


Additional Content

News | Cardiac Imaging

Nov. 2, 2026 – Conavi Medical Corp. has announced the completion of the first U.S. placement and clinical cases with ...

Home November 03, 2026
Home
News | Cardiac Imaging

Oct. 6, 2026 — Riverain Technologies has announced that its FDA-cleared ClearRead Chest suite will be available through ...

Home October 08, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Salus Scientific has launched its Clinical Insights Series, a new publication platform designed to share ...

Home August 17, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Ventripoint Diagnostics is expanding subscription-based access to its VMS+ 4.0, its FDA-cleared platform ...

Home August 14, 2026
Home
News | Cardiac Imaging

August 4, 2026 - Epsilon Imaging and ASCEND Cardiovascular have announced a strategic non-exclusive partnership designed ...

Home August 13, 2026
Home
Subscribe Now